168 related articles for article (PubMed ID: 36642171)
21. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
[TBL] [Abstract][Full Text] [Related]
22. Histopathology of cholestasis.
Desmet VJ
Verh Dtsch Ges Pathol; 1995; 79():233-40. PubMed ID: 8600686
[TBL] [Abstract][Full Text] [Related]
23. Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver.
Andrews TS; Nakib D; Perciani CT; Ma XZ; Liu L; Winter E; Camat D; Chung SW; Lumanto P; Manuel J; Mangroo S; Hansen B; Arpinder B; Thoeni C; Sayed B; Feld J; Gehring A; Gulamhusein A; Hirschfield GM; Ricciuto A; Bader GD; McGilvray ID; MacParland S
J Hepatol; 2024 May; 80(5):730-743. PubMed ID: 38199298
[TBL] [Abstract][Full Text] [Related]
24. Keratin 7 expression in hepatic cholestatic diseases.
Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
[TBL] [Abstract][Full Text] [Related]
25. Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool.
Devisscher L; Scott CL; Lefere S; Raevens S; Bogaerts E; Paridaens A; Verhelst X; Geerts A; Guilliams M; Van Vlierberghe H
Cell Immunol; 2017 Dec; 322():74-83. PubMed ID: 29111158
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of primary sclerosing cholangitis.
Pollheimer MJ; Halilbasic E; Fickert P; Trauner M
Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):727-39. PubMed ID: 22117638
[TBL] [Abstract][Full Text] [Related]
27. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans.
Li X; Liu R; Huang Z; Gurley EC; Wang X; Wang J; He H; Yang H; Lai G; Zhang L; Bajaj JS; White M; Pandak WM; Hylemon PB; Zhou H
Hepatology; 2018 Aug; 68(2):599-615. PubMed ID: 29425397
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling.
Schneider KM; Candels LS; Hov JR; Myllys M; Hassan R; Schneider CV; Wahlström A; Mohs A; Zühlke S; Liao L; Elfers C; Kilic K; Henricsson M; Molinaro A; Hatting M; Zaza A; Drasdo D; Frissen M; Devlin AS; Gálvez EJC; Strowig T; Karlsen TH; Hengstler JG; Marschall HU; Ghallab A; Trautwein C
Nat Metab; 2021 Sep; 3(9):1228-1241. PubMed ID: 34552267
[TBL] [Abstract][Full Text] [Related]
29. [Cholestatic liver diseases].
Grimm D; Thimme R
Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
[TBL] [Abstract][Full Text] [Related]
30. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
[TBL] [Abstract][Full Text] [Related]
31. Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up.
Khoshpouri P; Habibabadi RR; Hazhirkarzar B; Ameli S; Ghadimi M; Ghasabeh MA; Menias CO; Kim A; Li Z; Kamel IR
Radiographics; 2019; 39(7):1938-1964. PubMed ID: 31626561
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis.
Müller AL; Casar C; Preti M; Krzikalla D; Gottwick C; Averhoff P; Rosenstiel P; Gelderblom M; Altfeld M; Lohse AW; Steinmann S; Sebode M; Krause J; Schwinge D; Schramm C; Carambia A; Herkel J
J Hepatol; 2022 Dec; 77(6):1532-1544. PubMed ID: 35798133
[TBL] [Abstract][Full Text] [Related]
33. Characterization of animal models for primary sclerosing cholangitis (PSC).
Fickert P; Pollheimer MJ; Beuers U; Lackner C; Hirschfield G; Housset C; Keitel V; Schramm C; Marschall HU; Karlsen TH; Melum E; Kaser A; Eksteen B; Strazzabosco M; Manns M; Trauner M;
J Hepatol; 2014 Jun; 60(6):1290-303. PubMed ID: 24560657
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
Nakanishi Y; Saxena R
Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
[TBL] [Abstract][Full Text] [Related]
35. Lipopolysaccharide Lowers Cholesteryl Ester Transfer Protein by Activating F4/80
van der Tuin SJL; Li Z; Berbée JFP; Verkouter I; Ringnalda LE; Neele AE; van Klinken JB; Rensen SS; Fu J; de Winther MPJ; Groen AK; Rensen PCN; Willems van Dijk K; Wang Y
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29525783
[TBL] [Abstract][Full Text] [Related]
36. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
Ahn DW
Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
[TBL] [Abstract][Full Text] [Related]
37. The immunobiology of primary sclerosing cholangitis.
Aron JH; Bowlus CL
Semin Immunopathol; 2009 Sep; 31(3):383-97. PubMed ID: 19468733
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
39. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.
van Milligen de Wit AW; van Deventer SJ; Tytgat GN
Am J Gastroenterol; 1995 Jun; 90(6):893-900. PubMed ID: 7771416
[TBL] [Abstract][Full Text] [Related]
40. Hepatic failure after injury - a common pathogenesis with sclerosing cholangitis?
Zilkens C; Friese J; Köller M; Muhr G; Schinkel C
Eur J Med Res; 2008 Jul; 13(7):309-13. PubMed ID: 18700186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
